CUTANEOUS AND OCULAR TOXICOLOGY, vol.32, no.3, pp.204-209, 2013 (Journal Indexed in SCI)
Article / Article
Title of Journal :
CUTANEOUS AND OCULAR TOXICOLOGY
Context: The antimalarial drug hydroxychloroquine (HCQ), used in the treatment of rheumatologic disease, has been associated with the development of retinopathy. The long-term incidence of HCQ retinopathy has been estimated at 0.5% when recommended dosages (<= 6.5 mg/kg per day) are used.